CD274 and neoplasm: For instance, clinical studies demonstrated the association of liver metastasis with reduced response and shortened progression-free survival of PD-L1 checkpoint blockade therapy even for those originally well responding tumor types such as melanoma and non-small-cell lung cancer13,14.